Biomarker: M208-IgE Chaetomium globosum

Overview

M208-IgE Chaetomium globosum measures immunoglobulin E (IgE) antibodies directed against allergens from the mold Chaetomium globosum. Specific IgE indicates immune sensitization to the mold, which may be relevant to allergic rhinitis, asthma, or other mold-related respiratory symptoms, but it does not by itself establish clinical allergy or prove that exposure caused illness. Higher results indicate greater concentrations of detectable C. globosum-specific IgE, although the concentration does not reliably predict symptom severity. The test is clinically useful when interpreted with the patient’s exposure history, symptoms, and other allergy evaluation, particularly when routine mold testing does not identify a potential sensitizing fungus.

Clinical Use Cases

Evaluate suspected IgE-mediated sensitization to Chaetomium globosum in patients with allergic rhinitis, asthma, wheezing, or other compatible respiratory symptoms.
Support the assessment of possible indoor or occupational mold allergy when exposure to damp or water-damaged environments is reported.
Supplement skin-prick testing when skin testing is unsuitable, unavailable, or affected by medications such as antihistamines.
Identify less commonly tested fungal sensitization in patients with persistent asthma or allergic respiratory disease.
Contribute to allergen selection when an allergist is considering targeted exposure reduction or allergen immunotherapy. Clinical decisions should not be based on the result alone.

Specimen Types

Serum from venous blood is the usual specimen for quantitative allergen-specific IgE testing.
Whole blood may be collected initially, but serum is separated for analysis.
Skin-prick test material is an alternative in vivo assessment, but it is not a specimen type for the M208-IgE blood measurement.

Measurement Methods

Quantitative fluorescent enzyme immunoassay, such as an ImmunoCAP-based assay.
Enzyme-linked immunosorbent assay or immunoblotting methods in clinical research.
Results are commonly reported in kUA/L or equivalent allergen-specific IgE units and may be assigned an interpretive class by the testing laboratory.
Skin-prick testing is a related clinical method for detecting sensitization but measures the wheal-and-flare response rather than serum IgE.

Test Preparation and Influencing Factors

No fasting or other special preparation is generally required for an allergy blood test.
Tell the healthcare professional about all medicines and supplements. Do not stop antihistamines or other medicines unless specifically instructed.
Serum should be separated from cells promptly and handled according to the performing laboratory’s requirements; hemolyzed, icteric, or lipemic samples may be unsuitable.
Results should be interpreted with symptoms, timing and intensity of suspected exposure, seasonality, medical history, and other allergy findings.
A positive result indicates sensitization and does not necessarily mean that exposure causes symptoms.
A negative result does not completely exclude clinical allergy, particularly when the relevant allergen extract or assay has limited sensitivity.
Cross-reactivity among fungal allergens may affect interpretation.
The measured IgE concentration does not reliably predict the severity of a clinical reaction.